Back

Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in patients with atrial fibrillation: from asian perspectives

19 June 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial Fibrillation - Clinical and epidemiological aspects Clinical and epidemiological aspects (Atrial Fibrillation) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Associate Professor Ki Hong Lee

Chonnam National University Hospital, Gwangju (Korea (Republic of))

23 More presentations in this session

Presentation thumbnail
Doctor J. Ahn (Busan, KR)
Abstract
Presentation thumbnail
Doctor K. Nentwich (Bad Neustadt an der Saale, DE)
Abstract
Presentation thumbnail
Associate Professor K. Lee (Gwangju, KR)
Abstract Slides
Presentation thumbnail
Doctor C. Lefevre (Rueil-Malmaison, FR)
Abstract
Presentation thumbnail
Doctor K. Minami (Utsunomiya, JP)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Atrial Fibrillation - Clinical and epidemiological aspects

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

19 June 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources